Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
AstraZeneca
Chinese Patent Office
Deloitte
Chubb
Farmers Insurance
Cerilliant
Harvard Business School
Argus Health

Generated: June 22, 2018

DrugPatentWatch Database Preview

Pyridostigmine bromide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for pyridostigmine bromide and what is the scope of pyridostigmine bromide patent protection?

Pyridostigmine bromide
is the generic ingredient in three branded drugs marketed by Valeant Pharm Intl, Sandoz Inc, Valeant Pharms, Valeant Pharms Llc, Alvogen Malta, Impax Labs Inc, Kinedexe Uk, Ani Pharms Inc, Impax Labs, Solvay, Us Army, and Zydus Pharms Usa Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pyridostigmine bromide. Ten suppliers are listed for this compound.
Pharmacology for pyridostigmine bromide
Medical Subject Heading (MeSH) Categories for pyridostigmine bromide

US Patents and Regulatory Information for pyridostigmine bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040512-001 Oct 8, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms Llc MESTINON pyridostigmine bromide TABLET;ORAL 009829-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms MESTINON pyridostigmine bromide SYRUP;ORAL 015193-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl MESTINON pyridostigmine bromide INJECTABLE;INJECTION 009830-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Boehringer Ingelheim
Cantor Fitzgerald
Cerilliant
McKinsey
QuintilesIMS
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.